ClinicalTrialsFinder

Post-Transplant Lymphoproliferative Disorder Clinical Trials in Hillsborough, North Carolina

1 recruitingHillsborough, North Carolina

Showing 1–1 of 1 trials

Recruiting
Phase 2

Tafasitamab and Rituximab for Front-Line Treatment of Post-Transplant Lymphoproliferative Disorder

Monomorphic B-Cell Post-Transplant Lymphoproliferative DisorderPolymorphic Post-Transplant Lymphoproliferative Disorder
Timothy Voorhees28 enrolled4 locationsNCT05786040